Jon Skinner - 03 Feb 2025 Form 4 Insider Report for PULSE BIOSCIENCES, INC. (PLSE)

Reporting relationship: Chief Financial Officer
Issuer ticker: PLSE
Reported as of: 03 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Aug 2026, 19:17:14 UTC
Source filing: View source filing
Reporting owner signature: /s/ Kenneth B. Stratton

Key filing fact

Jon Skinner filed Form 4 for PULSE BIOSCIENCES, INC. (PLSE) on 28 Aug 2026.

Key facts

This page summarizes Jon Skinner's Form 4 filing for PULSE BIOSCIENCES, INC. (PLSE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Aug 2026, 19:17.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002078637 Primary reporting owner

Skinner Jon

Relationship: Chief Financial Officer
Address: C/O PULSE BIOSCIENCES, INC., 3957 POINT EDEN WAY, HAYWARD
Signature: /s/ Kenneth B. Stratton
Signature date: 28 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PLSE transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +300,000
Change %
Price: $0.000000^*
Shares after: 300,000
Date: 03 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 300,000
Exercise price: $20.93
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Half of the shares subject to the option will vest in equal installments on the first, second, third, and fourth anniversaries of the grant date and the remaining shares subject to the option will vest in equal tranches upon the achievement of four performance-based vesting criteria tied to both the Issuer's market capitalization ranging from $2 billion to $5 billion and GAAP revenue targets ranging from $48 million to $175 million, in all cases, subject to the Reporting Person's continued service through each vesting milestone.